Subscribe to Search results

Lord Cullen told the House of Lords that "There is a danger that Factor VIII, which has to be injected into haemophiliacs, can have in it a strain of hepatitis, and at the moment there is no way of testing for these strains. That is the one product as to whose freedom from infection we cannot be absolutely certain. However, every effort is made to see that it is not infected, and although occasionally something may happen, it is not of a serious nature."

Published on:

The World Health Organization Scientific Group reported that "The present widely employed techniques for detecting hepatitis B antigen in blood are thought to be capable of preventing approximately 30% of cases of post-transfusion hepatitis."

Published on:

In 1975, radioimmunological assay began to be used with greater sensitivity, though it still missed around one third of infections.

Published on:

In 1975 Alter et al published "Clinical and serological analysis of transfusion-associated hepatitis" in The Lancet.

Published on:

The Acute Viral Hepatitis B: CDR Reports 1975-79 reported that outbreaks of Hepatitis B continued in the 1970s.

Published on:

The Sub-Committee on AIDS of the Cabinet Home and Social Affairs Committee agreed to make £10 million available to people with haemophilia infected with HIV by blood products.

Published on:

A grant of up to £10 million was provided to help people with haemophilia infected with HIV by blood products.

Published on:

A memo proposed that people without haemophilia infected with HIV through blood transfusions should also have a claim for financial assistance.

Published on:

The Secretary of State had been asked "to give some thought to the feasibility of adjusting his proposed definition of eligibility so as to include the few known cases of non-haemophiliacs infected with the AIDS virus by NHS treatment."

Published on:

The Secretary of State had decided not to extend the compensation scheme to cover other groups outside of people with haemophilia.

Published on:

Malcolm Harris (Assistant Secretary in HS1) agreed that the compensation scheme should not be extended to cover other groups outside of people with haemophilia.

Published on:

The Haemophilia Society published a press release about the Hepatitis C infection of many people with haemophilia and its urgent consideration of the matter.

Published on:

A protocol for a pilot study to assess the introduction of routine anti-HCV tests in RTCs was drafted in November 1989 and carried out by Dr Gunson.

Published on:

The minutes of the UK Advisory Committee on Transfusion Transmitted Diseases meeting noted the policy regarding anti-Hepatitis C testing and that the focus should be on providing counselling services for those found to be anti-HCV positive.

Published on:

The minutes of the UK Advisory Committee on Transfusion Transmitted Diseases meeting noted the ACVSB agreed the anti-HCV test was a major step forward in identifying those who could transmit the virus, but that routine screening should not commence until the FDA had granted a license and that a cost benefit appraisal should be conducted and discussed with the Department of Health.

Published on:

The minutes of the UK Advisory Committee on Transfusion Transmitted Diseases meeting noted that ACVSB had deferred the decision to introduce routine screening for blood donations until April 1990.

Published on:

The agenda for the UK ACTTD meeting included Hepatitis C lookback, but there was no discussion of this recorded in the meeting minutes.

Published on:

The minutes of the UK Advisory Committee on Transfusion Transmitted Diseases meeting did not discuss Hepatitis C lookback.

Published on:

Dr Jean-Pierre Allain sent a fax to Dr Gunson with a proposal for HCV testing study that supported identifying and approaching all recipients of blood that was "screen positive (repeat reactive)".

Published on:

In a memo to Dr Thomson and Dr Mary Brennan, Dr Contreras suggested that an application should be made "as soon as possible" to the Medical Research Council and/or the Wellcome Foundation for funding in order to undertake a lookback for recipients of blood "who are now confirmed positive for HCV antibodies."

Published on: